Balaji Amines Ltd

Balaji Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Amines Ltd

₹ 1,821 -2.80%
27 May - close price
balajiamines.com BSE: 530999 NSE: BALAMINES
About

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]

Key Points

Market Leadership
The company is the largest manufacturer of aliphatic amines and their derivatives in India and the sole producer of a few specialty chemicals. [1]

Website BSE NSE
  • Market Cap ₹ 5,900 Cr.
  • Current Price ₹ 1,821
  • High / Low ₹ 1,957 / 905
  • Stock P/E 35.3
  • Book Value ₹ 610
  • Dividend Yield 0.60 %
  • ROCE 11.0 %
  • ROE 8.75 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 20.4%
  • Company's working capital requirements have reduced from 101 days to 68.5 days

Cons

  • Stock is trading at 2.99 times its book value
  • The company has delivered a poor sales growth of 1.72% over past five years.
  • Company has a low return on equity of 9.92% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE Commodities Nifty Microcap 250 Nifty Total Market BSE 1000 Nifty Smallcap 500

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
471 464 381 383 414 385 347 313 353 358 341 331 395
378 366 327 309 316 319 286 267 293 304 281 275 301
Operating Profit 93 98 54 74 98 66 61 46 60 55 60 57 94
OPM % 20% 21% 14% 19% 24% 17% 17% 15% 17% 15% 18% 17% 24%
6 6 7 8 9 8 9 8 8 9 7 5 8
Interest 3 2 2 2 1 1 1 1 1 1 1 2 2
Depreciation 11 11 11 11 12 12 12 12 13 14 14 14 14
Profit before tax 85 90 48 70 93 62 57 41 54 49 52 46 86
Tax % 35% 25% 24% 21% 22% 26% 27% 24% 25% 25% 28% 33% 25%
55 68 36 56 72 46 41 31 40 37 37 31 65
EPS in Rs 14.63 16.27 10.71 15.24 21.00 13.36 12.65 10.24 12.36 11.73 10.67 9.70 19.51
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
616 640 668 858 940 935 1,308 2,314 2,346 1,631 1,389 1,425
515 514 519 676 747 754 935 1,691 1,736 1,308 1,157 1,160
Operating Profit 102 127 149 182 193 181 373 623 609 324 232 265
OPM % 17% 20% 22% 21% 21% 19% 29% 27% 26% 20% 17% 19%
4 3 9 12 4 5 6 15 15 30 33 29
Interest 35 22 13 9 13 23 18 17 12 6 4 5
Depreciation 20 19 20 19 20 32 34 42 46 45 48 56
Profit before tax 51 88 126 166 165 131 327 578 567 302 213 232
Tax % 35% 34% 34% 32% 29% 26% 25% 28% 28% 23% 26% 27%
33 58 82 113 117 97 243 418 406 232 159 169
EPS in Rs 10.25 17.78 25.42 34.93 36.27 32.34 73.51 113.71 100.47 63.22 48.62 51.60
Dividend Payout % 12% 11% 9% 7% 8% 10% 5% 5% 10% 17% 23% 21%
Compounded Sales Growth
10 Years: 8%
5 Years: 2%
3 Years: -15%
TTM: 3%
Compounded Profit Growth
10 Years: 11%
5 Years: -7%
3 Years: -20%
TTM: 6%
Stock Price CAGR
10 Years: 24%
5 Years: -9%
3 Years: -5%
1 Year: 22%
Return on Equity
10 Years: 18%
5 Years: 16%
3 Years: 10%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 221 274 356 461 568 652 888 1,243 1,548 1,715 1,839 1,970
256 173 105 152 227 260 127 101 58 20 11 133
139 152 168 229 244 195 289 395 351 405 396 633
Total Liabilities 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146 2,252 2,743
341 341 325 316 320 573 543 681 780 896 1,003 1,043
CWIP 3 16 25 123 269 46 173 141 113 205 238 512
Investments 0 0 0 0 0 48 0 0 73 0 0 0
278 248 284 409 457 446 594 923 996 1,046 1,011 1,188
Total Assets 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146 2,252 2,743

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
56 85 60 140 94 144 110 220 354 334 255 184
-4 -29 -10 -135 -119 -130 -62 -147 -210 -274 -139 -344
-55 -54 -55 16 21 -26 -37 -57 -81 -75 -49 85
Net Cash Flow -3 2 -5 21 -4 -12 11 16 63 -15 68 -75
Free Cash Flow 48 53 47 32 -75 83 -21 72 234 82 70 -10
CFO/OP 65% 77% 58% 101% 74% 108% 40% 56% 81% 123% 128% 82%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 71 71 68 73 65 81 85 93 59 71 72 89
Inventory Days 114 80 106 70 116 77 64 66 89 116 128 113
Days Payable 48 58 55 56 60 42 44 54 18 31 32 39
Cash Conversion Cycle 136 93 119 87 120 116 104 105 129 156 168 163
Working Capital Days 7 12 42 31 47 55 88 88 89 114 120 69
ROCE % 18% 23% 30% 32% 24% 18% 35% 49% 36% 17% 11% 11%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Aliphatic Amines Sales Volume
MT ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Amine Derivatives Sales Volume
MT ・Standalone data
Consolidated Sales Volume
MT
Specialty Chemicals Sales Volume
MT ・Standalone data
N-Butylamine Capacity Utilization
% ・Standalone data
Total Installed Capacity
TPA ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 54.62% 54.59% 54.59% 54.59% 54.59%
4.55% 4.52% 4.58% 4.92% 5.05% 5.27% 5.16% 5.09% 5.00% 4.53% 3.30% 2.99%
0.18% 0.90% 1.43% 1.48% 1.59% 1.79% 1.66% 1.48% 1.46% 1.52% 1.53% 1.46%
41.57% 40.88% 40.31% 39.91% 39.67% 39.23% 39.46% 38.83% 38.96% 39.37% 40.59% 40.96%
No. of Shareholders 1,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,3611,27,4421,21,9501,18,8941,17,5911,15,754

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls